World Alzheimer Report 2016: Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs now and in the future. Available online: https://www.alz.co.uk/research/world-report-2016 (accessed on 24 November 2016).
 Alwan A, Maclean DR, Riley LM, d’Espaignet ET, Mathers CD, Stevens GA, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376(9755):1861‐68.
 Xu J, Wang J, Wimo A, Fratiglioni L, Qiu C. The economic burden of dementia in China, 1990-2030: implications for health policy. Bull World Health Organ. 2017;95(1):18‐26.
 Jia JP, Wei CB, Chen SQ, Li FY,Tang Y,Qin W, et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483‐91.
 Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673‐34.
 Petersen RC. Normal aging, mild cognitive impairment, and early Alzheimer's disease. Neurologist. 1995; 1(6): 326-44.
 Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, O.Wahlund L, et al.MCI toward a consensus. Journal of Internal Medicine.2004;256:240-46.
 Morris JC, Cummings J. Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J Alzheimers Dis. 2005;7(3):235‐62.
 Busse A, Angermeyer MC, Riedel-Heller SG.Progression of mild cognitive impairment to dementia: a challenge to current thinking. Br J Psychiatry. 2006;189:399‐404.
 Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. The Lancet.2006;367(9518): 1262-70.
 Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183‐94.
 Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr.. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66(12):1447‐55.
 Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement, 2012, 8(1): 14-21.
 Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126‐35.
 Lara E, Koyanagi A, Olaya B, Lobo A, Miret M, Tyrovolas S,et al. Mild cognitive impairment in a Spanish representative sample: prevalence and associated factors. Int J Geriatr Psychiatry. 2016;31(8):858‐67.
 Brucki SMD. Epidemiology of mild cognitive impairment in Brazil. Dement Neuropsychol. 2013;7(4):363‐66.
 Alkhunizan M, Alkhenizan A, Basudan L. Prevalence of Mild Cognitive Impairment and Dementia in Saudi Arabia: A Community-Based Study. Dement Geriatr Cogn Dis Extra. 2018;8(1):98‐103.
 Bae S, Shimada H, Lee S, Makizako H, Lee S, Harada K,et al. The Relationships Between Components of Metabolic Syndrome and Mild Cognitive Impairment Subtypes: A Cross-Sectional Study of Japanese Older Adults. J Alzheimers Dis. 2017;60(3):913-21.
 Sosa AL, Albanese E, Stephan BC, Dewey M, Acosta D, Ferri CP, et al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS Med. 2012;9(2):e1001170.
 Jia J, Zhou A, Wei C, Jia XF, Wang F, Li F, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439‐47.
 Nie H, Xu Y, Liu B, Zhang YD, Lei T, Hui XP, et al. The prevalence of mild cognitive impairment about elderly population in China: a meta-analysis. Int J Geriatr Psychiatry. 2011;26(6):558‐63.
 Xue J, Li J, Liang JM, Chen SL. The Prevalence of Mild Cognitive Impairment in China: A Systematic Review. Aging Dis. 2018;9(4):706‐15.
 Yang L, Qin QB. Study on prevalence and risk factors of mild cognitive impairment among retired cadres. Chinese Journal of Nervous and Mental Diseases.2011;37(8): 473-6.
 Qiu CJ, Tang MN, Zhang W, Han HY, Dai J, Lu J, et al. The prevalence of mild cognitive impairment among residents aged 55 or over in Chengdu area. Chin J Epidemiol.2003; 24(12): 1104-7.
 Lee SB, Kim KW, Youn JC, Park JH, Lee JJ, Kim MH, et al. Prevalence of mild cognitive impairment and its subtypes are influenced by the application of diagnostic criteria: results from the Korean Longitudinal Study on Health and Aging (KLoSHA). Dement Geriatr Cogn Disord. 2009;28(1):23‐29.
 Bondi MW, Smith GE. Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology. J Int Neuropsychol Soc. 2014;20(2):129‐34.
 Kaur J, Sidhu B, Sibia R, Kaur B. Prevalence of Mild Cognitive Impairment among Hospital Patiens aged 65 and Above. J Delhi Psychiatry Journal. 2014, 17(1): 60-4.
 Ni HJ, Qin JL, Zhou LP, Zhao ZG, Wang J, Hou FZ, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Network analysis in detection of early-stage mild cognitive impairment. Physica A-statistical mechanics and its applications. 2017; 478:113-9.
 Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C,et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol.2012;65(9): 934-9.
 Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J,et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383‐94.
 Janoutova J, Ambroz P, Kovalova M, Machaczka O, Němček K, Zatloukalová A,et al. Epidemiology of mild cognitive impairment. Ceska a Slovenska Neurologie a Neurochirurgie.2018;81(3): 284-9.
 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629‐34.
 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557‐60.
 Lipsey MW, Wilson DB. Practical meta-analysis [M]. Sage Publications, Inc, 2001.
 Chen ND, Du J, Yang Y, Li D, Xu LB,Li W, et al. Comparation of two diagnostic criteria on mild cognitive impairment in an elderly cohort. Journal of Neuroscience and Mental Health.2014;14(3): 247-50.
 Ding D, Zhao QH, Guo QH, Meng HJ, Wang B, Luo JF, et al. Prevalence of mild cognitive impairment in an urban community in China: a cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement. 2015;11(3):300‐9.e2.
 Guo GY, Tan GY, Zhang SF, Yu XD, Li CL,et al. Status analysis of mild cognitive im pairment of the elderly in Chengde City. China Medical Herald.2013;10(6): 110-1.
 Guo XY, Zhao LM, Li XM, Yang Q, et al. Prevalence of mild cognitive impairment among rural Chinese elderly. Chin J Mult Organ Dis Elderly.2013;12(12): 904-7.
 Hai S, Dong BR, Liu YX, Zou YP. Occurrence and risk factors of mild cognitive impairment in the older Chinese population: a 3-year follow-up study. Int J Geriatr Psychiatry. 2012;27(7):703‐8.
 He L. Assessment and intervention study of mild cognitive impairment in the elderly in community of Jiangxi Province [D]. NanChang University, 2015.
 Hu R, Zhao SG, Wang DS, Wen SR, Niu GM, A Rong, et al. A prevalence study on mild cognitive impairment among the elderly populations of Mongolian and Han nationalities in a pastoral area of Inner Mongoli a. Chin J Epidemiol.2012;33(4): 364-7.
 Huang R, Tang MN, Ma C, Guo YB, Han HY, Huang JM, et al. The prevalence of mild cognitive impairment of residents aged 60 years and over in the urban and rural areas in Guangzhou. Chin J Nerv Ment Dis.2008;34(9): 533-7.
 Jiang LJ. The follow-up study of assessment, classification, and intervention of the cognitive impairment in the elderly in the Changchun south lake community [D]. JiLin University, 2017.
 Lao ML, Zhang HY, Luo G, Yi XN, Huang YD, Wu ZH,et al. Prevalence of mild cognitive impairment amony 55-years old or over individuals in Hainan Island. Hainan Medical Journal.2011;22(14): 112-4.
 Li CP, Wang Y, Tian F, Liu X, Liang YJ, Zhang WX, et al. Prevalence and risk factors of mild cognitive impairment among rural Chinese elderly. Chinese Journal of Gerontology. 2015;35:3404-7.
 Li W, Sun L, Xiao SF. Prevalence, Incidence, Influence Factors, and Cognitive Characteristics of Amnestic Mild Cognitive Impairment Among Older Adult: A 1-Year Follow-Up Study in China. Front Psychiatry.2020;11:75.
 Li X, Ma C, Zhang J, Liang Y, Chen YJ, Chen KW, et al. Prevalence of and Potential Risk Factors for Mild Cognitive Impairment in Community-Dwelling Residents of Beijing. Journal of the American Geriatrics Society.2013; 61(12): 2111-9.
 Liao B, Gao R, Xiong LH, Yi GP, Sheng ZJ，Liu MG，et al. The Early Evaluation and Intervention Strategies of Mild Cognitive Impairment in Yichun Area. Journal of Yichun College.2012;34(12): 77-9.
 Liu H, Zeng QZ, Zhuang XW, Chen YM. Investigation analysis of mild cognitive impairment of the elderly in the community of some District in Shanghai and study of the intervention methods and effects. Journal of international psychiatry.2018;45(2): 288-91,301.
 Ma F, Wu TF, Zhao JG, Li L, Song AL, Zhang ML, et al. Prevalence of Mild Cognitive Impairment and Its Subtypes among Chinese Older Adults: Role of Vascular Risk Factors. Dement Geriatr Cogn Disord. 2016;41(5-6):261‐72.
 Meng WQ. Cigarette Smoking and Alcohol Consumption in Relation to mild cognitive impairment in old people in Inner Mongolia [D]. Inner Mongolia University, 2010.
 Pan ZD, Zhou RS, Wang T, Xian SF. Prevalence of mild cognitive impairment among the elderly in community. Geriatr Health Care.2012;18(3): 154-6.
 Qin HY, Chen DH, Qu ZW. Investigation of mild cognitive impairment and its risk factors among 55 years old and above residents in Shanghai. J Clin Psychiatry.2014;24(3): 155-8.
 Rao DP, Luo X, Tang MN, Shen Y, Huang RY, Yu JC, et al. Prevalence of mild cognitive impairment and its subtypes in community-dwelling residents aged 65 years or older in Guangzhou, China. Arch Gerontol Geriatr. 2018;75:70‐5.
 Ren CF, Yuan YF, Zhang Y, Wang JL，Lu HL，Wan AL，et al. Analysis on prevalence and influencing factors of mild cognitive impairment among the elderly in Jiangxi Communitie. Modem Preventive Medicin.2013;40(21): 3969-73.
 Song XZ, Chen JH, He LP. Investigation on correlation between prevalence of the mild cognitive impairment and eating habit in elderly in the communities of Shunde city. IMHGN.2012;18(12): 1715-8.
 Su C. Cognitive features and normal elderly cognitive function change rule among residents aged 60 years and over in Guangzhou city [D].Guangzhou University, 2010.
 Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, Lin CC, et al. A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan. PLoS One. 2014;9(6):e100303. Published 2014 Jun 18.
 Tang MN, Liu XH, Yun Y, Han HY, Tang MM, Ren H, et al. A follow-up study ofmild cognitive impairment and senile dementia in the urban and rural aged population in Chengdu. Chin J Psychiatry. 2000;33(4): 218-21.
 Tang Z, Zhang XQ, WU XG, Liu HJ ,diao LJ, Guan SC ,et al. Prevalence of the Mild Cognitive Impairment among Elderly in Beijing. Chinese Mental Health Journal.2007;21(2): 116-8.
 Wang T, Xiao SF, Chen KW, Yang CC, Dong SH, Cheng Y, et al. Prevalence, Incidence, Risk and Protective Factors of Amnestic Mild Cognitive Impairment in the Elderly in Shanghai. Curr Alzheimer Res.2017;14(4):460‐6.
 Wang TT, Cao C, Deng J, Lian JX, Yan K, Wang ZZ, et al. Prevalence and Risk Factors of Mild Cognitive Impairment among Old People in Chongqing. Chin J Rehabil Theory Pract. 2017;23(7): 833-8.
 Wang YP, Zhai JB, ZHU F, Zhang WW，Yang XJ，Qu CY, et al. A three-year follow-up study on the transfer of mild cognitive impairment to Alzheimer’s disease among the elderly in Taiyuan city. Chin J Epidemiol.2011;32(2): 105-9.
 Wang ZZ, Ding L, Liu L, Li T, Ma WR, Zhang JL, et al. The status of mild cognitive impairment in the Hui and Han people aged 55 years and above in Ningxia . Chin J Gerontol.2013;36:4601-3.
 Wu Y, Yao JJ, Chen ZH, YangQP, Zhou DX, FengW, et al. Survey on mild cognitive impairment and analysis of its influencing factors among community elderly in Wuxi City. Modern Preventive Medicine. 2017;44(2): 259-63.
 Xiao SF, Lewis M, Mellor D, McCabe M, Byrne L, Wang T, et al. The China longitudinal ageing study: overview of the demographic, psychosocial and cognitive data of the Shanghai sample. J Ment Health. 2016;25(2):131‐136.
 Xu SJ, Xie B, Song M, Yu LL, Wang L, An CX,et al. High prevalence of mild cognitive impairment in the elderly: a community-based study in four cities of the Hebei province, china. Neuroepidemiology. 2014;42(2):123‐30.
 Yin LY. Investigation and diagnosis of mild cognitive impairment [D].HeBei University, 2010.
 Yuan J, Qu ZW, Jiang Q, Yang ZD ,Fu WZ et al. The epidemiological survey of depression disorder and cognitive disorder of the elderly in Shanghai Pudong community. J Chin Psychiatry. 2013;23(2): 86-8.
 Zhang XQ, Hu Z. Prevalence and Factors Associated with Mild Cognitive Impairment among the Elderly in Changsha Communities. Chinese General Practice. 2014;17(9): 1031-5.
 Zhou DS, Xu YE, Chen ZM, Hu ZY, Chen YF. Prevalence of mild cognitive impairment among the elderly. Chin J Public Health.2011;27(11): 1375-7.
 Zhu XQ, Zhou XH , Kumusi B,Yue YH, Zhao RJ, Xin SF, et al. Study of prevalence of the mild cognitive impairment among elderly in the communities of Urumqi city. Journal Of Xinjiang Medical University. 2009;32(5): 578-84.
 Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189‐98.
 Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment [published correction appears in J Am Geriatr Soc. 2019 Sep;67(9):1991]. J Am Geriatr Soc. 2005;53(4):695‐99.
 Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. the index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914‐9.
 MORRIS J C. The clinical dementia rating (CDR): Current version and scoring rules. Neurology., 1993;43(11): 2412-4.
 ASSOCIATION A P. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., [M]. Washington, D.C.: American Psychiatric Association, 1994.
 Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270‐79.
 Pan HY, Wang JQ, Wu ML, Chen JJ. Study on prevalence rate and quality of life of elderly patients with mild cognitive impairment in community. Nurs J Chin PLA.2012;29(1B):6-9,27.
 Peng ZR, Jiang H, Wang XM, Huang KY, Zuo YK, Wu XM,et al. The Efficacy of Cognitive Training for Elderly Chinese Individuals with Mild Cognitive Impairment. Biomed Res Int. 2019;2019:4347281. Published 2019 Nov 30.
 Wu L, He Y, Jiang B, Liu M, Wang JH, Yang SS,et al. The association between the prevalence, treatment and control of hypertension and the risk of mild cognitive impairment in an elderly urban population in China. Hypertens Res. 2016;39(5):367‐75.
 Zhong SY,Tong ZD,Hu BX，Yuan XB，Chen W，Zhang FN，et al. Prevalence and influencing factors of mild cognitive impairment among the elderly in Zhoushan City. Prev Med.2018; 30(2): 170-2.
 Vlachos GS, Kosmidis MH, Yannakoulia M, Dardiotis E, Hadjigeorgiou G, Sakka P,et al. Prevalence of Mild Cognitive Impairment in the Elderly Population in Greece: Results From the HELIAD Study. Alzheimer Dis Assoc Disord. 2020;34(2):156‐62.
 Janelidze M, Mikeladze N, Bochorishvili N, Dzagnidze A, Kapianidze M, Mikava N, et al. Mild Cognitive Impairment in Republic of Georgia. Gerontol Geriatr Med. 2018;4:2333721418771408. Published 2018 May 4.
 Hänninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H. Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand. 2002;106(3):148‐54.
 Tognoni G, Ceravolo R, Nucciarone B, Bianchi F, Dell'Agnello G, Ghicopulos I,et al. From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. Acta Neurol Scand. 2005;112(2):65‐71.
 Juarez-Cedillo T, Sanchez-Arenas R, Sanchez-Garcia S, Garcia-Peña C, Hsiung GY, Sepehry A, et al. Prevalence of mild cognitive impairment and its subtypes in the Mexican population. Dement Geriatr Cogn Disord. 2012;34(5-6):271‐81.
 Brucki SMD. Epidemiology of mild cognitive impairment in Brazil. Dement Neuropsychol. 2013;7(4):363‐6.
 Moretti, F, De Ronchi, D, Palmer, K, Forlani, C, Morini, V, Ferrari, B, et al.Prevalence and characteristics of mild cognitive impairment in the general population. Data from an Italian population-based study: The Faenza Project. Aging Ment Health. 2013; 17(3): 267-275.
 Henao-Arboleda, E, Aguirre-Acevedo, DC, Munoz, C, Pineda, DA, Lopera, F. Prevalence of mild cognitive impairment, amnestic-type, in a Colombian population. 2008; 46(12): 709-713.
 Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology. 2010;75(10):889‐97.
 Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry. 2003;182:449‐54.
 Brodaty H, Heffernan M, Kochan NA, Draper B, Trollor JN, Reppermund S, et al. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Alzheimers Dement. 2013;9(3):310‐17.e1.
 Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L. CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol. 1995;34(4):529‐41.
 Cheng ZH, JR S. Theoretic Framework of Chinese Cognitive Ability Scale. Chinese Journal of Clinical Psychology.2006;14(4): 340-2
Hall KS, Hendrie HC, Brittain HM, Norton JA, Rodgers DD. The Development of a dementia screening interview in two distinct languages. International Journal of Methods in Psychiatric Research.1993;3:1-28.
Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233‐9.
 Wu Y, Xu WW, Zao HC. Quick cognitive screening scale for the elder: development,reliability and validity . Chin J Behav Med & Brain Sci.2013;12(22): 1129-32.
 Bright P, Hale E, Gooch VJ, Myhill T, van der Linde I. The National Adult Reading Test: restandardisation against the Wechsler Adult Intelligence Scale-Fourth edition. Neuropsychol Rehabil. 2018;28(6):1019‐27.
 Liu YY, Wang T, Li X, Li GJ,Su N, Xiao SF. Reliability and validity of the Chinese version of neuropsychological test battery. Chin J Clinicians.2011;5(5): 1339-45.
Ustun TB, Kostanjsek N, Chatterji S, Rehm, J.Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva:World Health Oragnization,In press, 2010.
 Wang P, Li J, Li H, Zhang S. Differences in learning rates for item and associative memories between amnestic mild cognitive impairment and healthy controls. Behav Brain Funct. 2013;9(1):29.
 Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797‐811.
 Wechsler D. Wechsler Memory Scale-Revised Manual. San Antonio, TX: The Psychological Corporation, 1987.
 Sheridan LK, Fitzgerald HE, Adams KM, Nigg JT, Martel MM, Puttler LI, et al. Normative Symbol Digit Modalities Test performance in a community-based sample. Arch Clin Neuropsychol. 2006;21(1):23‐8.
 Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-6.
 Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS. Screening for Alzheimer's disease by clock drawing. J Am Geriatr Soc. 1989;37(8):730‐4.
 Tupler LA, Welsh KA, Asare-Aboagye Y, Dawson DV. Reliability of the Rey-Osterrieth Complex Figure in use with memory-impaired patients. J Clin Exp Neuropsychol. 1995;17(4):566‐9.
 Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. 1994;51(1):51‐61.
 Lezak MD. Neuropsychological Assessment, 5th ed, [M]. New York:Oxford University Press,2012.
 Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323‐9.
 Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997;12(2):277‐87.
 Leung JL, Lee GT, Lam YH, Chan RC, Wu JY. The use of the Digit Span Test in screening for cognitive impairment in acute medical inpatients. Int Psychogeriatr. 2011;23(10):1569‐74.
Hamilton M. A rating scale for depression . J Neurol Neurosurg Psychiatry, 1960, 23:56– 62.
Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136‐9.
Copeland JR, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med. 1986;16(1):89‐99.
 Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371‐9.
 Hachinski VC, Iliff LD,Zilhka E,Boulay GH,McAllister VL,Marshall J. Cerebral Blood Flow in Dementia. Archives of Neurology.1975; 32(9): 632-7.
 Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, et al, Global Health Epidemiology Reference Group (GHERG). Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013;381(9882):2016‐23.
 Petersen RC, O'BRIEN J. Mild cognitive impairment should be considered for DSM-V [M]. Diagnostic issues in dementia: Advancing the research agenda for DSM-V. Arlington, VA; American Psychiatric Association; US. 2007: 51-65.
Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimers Dement. 2018;14(2):121‐9.
 Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JM, Hicks T, Schneider T, et al. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis [published correction appears in Alzheimers Dement. 2017 Oct;13(10 ):1185]. Alzheimers Dement. 2017;13(8):841‐9.
Au B, Dale-McGrath S, Tierney MC. Sex differences in the prevalence and incidence of mild cognitive impairment: A meta-analysis. Ageing Res Rev. 2017;35:176‐99.
 Gavrila D, Antúnez C, Tormo MJ, Carles R, García Santos JM, Parrilla G,et al. Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study. Acta Neurol Scand. 2009;120(5):300‐7.
 LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA. 2001;285(11):1489‐99.
Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F,et al, Italian Longitudinal Study on Aging Working Group. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology. 2004;63(10):1882‐91.
 Afgin AE, Massarwa M, Schechtman E, Israeli-Korn SD, Strugatsky R, Abuful A, et al. High prevalence of mild cognitive impairment and Alzheimer's disease in arabic villages in northern Israel: impact of gender and education. J Alzheimers Dis. 2012;29(2):431‐9.
 Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819‐28.
 Plassman BL, Williams JW Jr, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 2010;153(3):182‐93.
 Meng X, D'Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7(6):e38268.
Pettigrew C, Soldan A. Defining Cognitive Reserve and Implications for Cognitive Aging. Curr Neurol Neurosci Rep. 2019;19(1):1. Published 2019 Jan 9.
Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, et al. Prevalence of Depression in Patients With Mild Cognitive Impairment: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017;74(1):58‐67.
Nunes B, Silva RD, Cruz VT, Roriz JM, Pais J, Silva MC. Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal. BMC Neurol. 2010;10:42. Published 2010 Jun 11.
 Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health. 2014;14:643. Published 2014 Jun 24.
Ng TP, Feng L, Nyunt MS, Feng L, Gao Q, Lim ML, Collinson SL, Chong MS, et al. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort. JAMA Neurol. 2016;73(4):456‐63.
 Pal K, Mukadam N, Petersen I, Cooper C. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2018;53(11):1149‐60.
 Zhang X, Dupre ME, Qiu L, Zhou W, Zhao Y, Gu D. Urban-rural differences in the association between access to healthcare and health outcomes among older adults i0n China. BMC Geriatr. 2017;17(1):151. Published 2017 Jul 19.